Evaluating the State of Microvessels by Minimum Rise Time (MRT01)
- Conditions
- Healthy
- Interventions
- Device: RESPeRATE (Paced Breathing)Device: Quantum Warp10 (Red LED)Device: Omnilux new-U (Near Infrared LED)Other: Heat/cold provocation
- Registration Number
- NCT02527070
- Lead Sponsor
- Afeka, The Tel-Aviv Academic College of Engineering
- Brief Summary
Photoplethysmography (PPG) is a simple uncalibrated optical method of monitoring variations in skin blood volume. The objective of the current study is to investigate a potential relationship between MRT (minimum rise time, in time units) a measure derived from PPG and the state of microvessels.
This study includes a 1-2 hour single session per subject during which PPG and other microvascular and systemic variables will be monitored in response to non-invasive interventions that are known to elicit microvascular responses.
- Detailed Description
Photoplethysmography (PPG) is a simple uncalibrated optical method of monitoring variations in skin blood volume. A major limitation of PPG is the lack of a quantitative method for calibrating this signal. A method that provides an absolute measure (in time units) called 'minimum rise time' (MRT) was published in 1985 by Dr. Benjamin Gavish, one of the study investigators. However, a possible relationship between MRT and the state of arterioles that determines the microvascular flow has never been investigated. Such relationship, if validated, could have clinical impact in noninvasive diagnosis of vascular diseases and monitoring microvascular response to treatments that affect at both clinic and home setting.
The objective of the current study is to investigate a potential relationship between variations of MRT (minimum rise time, in time units) and microcirculatory variables induced by interventions that are expected to have acute effect on the state of arterioles and the tissue oxygenation.
This study includes a single 1-2 hour session per subject, during which PPG and other microvascular and systemic variables will be monitored in healthy volunteers in response to a number of non-invasive interventions/device that are approved for clinical use and known to elicit microvascular responses. These interventions are applied consecutively, include breathing at different rates, low power visible light in the red-to-near-infrared range, and local temperature changes. The experimental sessions will be conducted at the Afeka College by the study investigators.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 33
- Healthy males and females, between 18 and 65 years of age.
- Willing to sign informed consent.
- Currently smoking
- Any abnormal skin condition in the area of light irradiation.
- Pregnant having given birth less than 3 months ago, and/or breastfeeding.
- Having a history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treated area, unless treatment is conducted following a prophylactic regimen.
- Having any illness that might affect the vasculature, such as diabetes (type I or II)
- Suffering from significant concurrent illness, such as cardiac disorders, , or pertinent neurological disorders.
- As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Red LED RESPeRATE (Paced Breathing) Light emitting diodes, 670 nm, 50 mW/cm2, Quantum Warp10 (Quantum Devices Inc, Barneveld, WI, USA); RESPeRATE; Heat/cold provocation Red LED Quantum Warp10 (Red LED) Light emitting diodes, 670 nm, 50 mW/cm2, Quantum Warp10 (Quantum Devices Inc, Barneveld, WI, USA); RESPeRATE; Heat/cold provocation Red LED Heat/cold provocation Light emitting diodes, 670 nm, 50 mW/cm2, Quantum Warp10 (Quantum Devices Inc, Barneveld, WI, USA); RESPeRATE; Heat/cold provocation Near Infrared LED Omnilux new-U (Near Infrared LED) Light emitting diodes, 830 nm, 55 mW/cm2, Omnilux new-U (Photomedex, Horsham, PA, USA); RESPeRATE; Heat/cold provocation Near Infrared LED Heat/cold provocation Light emitting diodes, 830 nm, 55 mW/cm2, Omnilux new-U (Photomedex, Horsham, PA, USA); RESPeRATE; Heat/cold provocation Near Infrared LED RESPeRATE (Paced Breathing) Light emitting diodes, 830 nm, 55 mW/cm2, Omnilux new-U (Photomedex, Horsham, PA, USA); RESPeRATE; Heat/cold provocation
- Primary Outcome Measures
Name Time Method MRT as measured from finger Photoplethysmography in response to changes in breathing rate Change from baseline to up to 1 minute after termination of 2 minutes of constant breathing rate (15, 10, and 6 breath/min) MRT as measured from finger Photoplethysmography in response to light source Change from immediately before exposure to light source to up to 10 minutes after exposure to light source MRT as measured from finger Photoplethysmography in response to temperature changes Change from immediately before exposure to temperature provocations to up to 2 minutes after exposure to warm water, and up to 2 minutes after exposure to cold water
- Secondary Outcome Measures
Name Time Method Capillary blood flow (red blood cell velocity or flux in 'perfusion units') as measured by laser doppler At baseline, 1 minute after each changes in breathing rate, 5 and 10 minutes after exposure to light source, 1 minutes after each exposure to temperature changes Transcutaneous oxygen pressure (tcpO2 in mmHg) At baseline, 1 minute after each changes in breathing rate, 5 and 10 minutes after exposure to light source, 1 minutes after each exposure to temperature changes
Trial Locations
- Locations (1)
Afeka, Tel-Aviv Academic College of Engineering
🇮🇱Tel Aviv, Israel